Questcor Pharmaceuticals, Inc. (QCOR)
-NasdaqGS 37.34 
0.48(1.30%) May 17, 4:00PM EDT|After Hours
:
37.84 0.50 (1.34%) May 17, 7:05PM EDT
| Prev Close: | 36.86 |
|---|
| Open: | 37.40 |
|---|
| Bid: | 35.87 x 800 |
|---|
| Ask: | 46.02 x 100 |
|---|
| 1y Target Est: | 48.25 |
|---|
| Beta: | 0.83 |
|---|
| Next Earnings Date: | 24-Jul-13 |
|---|
| Day's Range: | 36.76 - 37.97 |
|---|
| 52wk Range: | 17.25 - 58.91 |
|---|
| Volume: | 1,084,664 |
|---|
| Avg Vol (3m): | 2,028,960 |
|---|
| Market Cap: | 2.16B |
|---|
| P/E (ttm): | 11.56 |
|---|
| EPS (ttm): | 3.23 |
|---|
| Div & Yield: | 1.00 (2.70%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Outlook for the Most Shorted Stocksat Motley Fool(Fri, May 17)
- Analyst Favorites With Strong Buyback Activity: Questcor Pharmaceuticals Ranks As a Top Pickat Forbes(Fri, May 17)
- 3 Value Investing Plays in Health Careat Motley Fool(Thu, May 16)
- EBay CTO Sells More Than 111K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Thu, May 16)
- Wal-Mart Takes Up Safety Standards Solo, Broadcom’s Dividend, and 3 More Hot Stocksat Wall St. Cheat Sheet(Wed, May 15)
- Questcor Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)at Seeking Alpha(Tue, May 14)
- Questcor Rises On Unusually High Volume (QCOR)at TheStreet(Tue, May 14)
- Questcor bears are running for coveroptionMONSTER(Tue, May 14)
- QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon, May 13)
- 10 Hot Healthcare Dogs Probe 6% To 38.2% Gains In Aprilat Seeking Alpha(Mon, May 13)
- QUESTCOR PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Fri, May 10)
- Analysts Say These Dividend Stocks Are Undervaluedat Seeking Alpha(Fri, May 10)
- Dividend Stocks On Sale As The Market Hits New Highsat Seeking Alpha(Thu, May 9)
- Why Questcor Is Undervaluedat Motley Fool(Wed, May 8)
- Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare ConferencePR Newswire(Wed, May 8)
Key Statistics
| Forward P/E (1 yr): | 7.98 |
|---|
| P/S (ttm): | 3.89 |
|---|
| Ex-Dividend Date: | 18-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.95 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.97 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | 0.42 |
|---|
Business Summary
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications.
View More